drugset / Trial / NCT00641147
Curcumin in Treating Patients With Familial Adenomatous Polyposis
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized phase II trial studies curcumin in treating patients with familial adenomatous polyposis. Curcumin may prevent colorectal cancer in patients with a history of rectal polyps or colorectal neoplasia.
Timeline
- Start
- 2010-10
- Primary completion
- 2016-11
- Completion
- 2016-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 1500 mg | Oral |